sb 203580 has been researched along with Hypertrophy in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (80.00) | 29.6817 |
| 2010's | 1 (20.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Brown, D; Hikim, AP; Kovacheva, EL; Sinha-Hikim, I | 1 |
| Fahmi, A; Heads, R; Jabr, R; Marber, M; Punn, A; Smart, N | 1 |
| Butler-Browne, GS; Furling, D; Jacquemin, V; Mouly, V | 1 |
| Basoni, C; Ezan, J; Génot, E; Kramer, I; Reuzeau, E; Rottiers, P; Varon, C | 1 |
| Bogoyevitch, MA; Long, CS; Ng, DC | 1 |
5 other study(ies) available for sb 203580 and Hypertrophy
| Article | Year |
|---|---|
Mouse model of testosterone-induced muscle fiber hypertrophy: involvement of p38 mitogen-activated protein kinase-mediated Notch signaling.
Topics: Animals; Cell Proliferation; Disease Models, Animal; Enzyme Activation; Enzyme Inhibitors; Hypertrophy; Imidazoles; Male; Mice; Mice, Inbred C57BL; Muscle Fibers, Skeletal; Muscular Diseases; Myogenin; p38 Mitogen-Activated Protein Kinases; Proliferating Cell Nuclear Antigen; Pyridines; Receptors, Notch; Signal Transduction; Testosterone | 2009 |
p42/p44-MAPK and PI3K are sufficient for IL-6 family cytokines/gp130 to signal to hypertrophy and survival in cardiomyocytes in the absence of JAK/STAT activation.
Topics: Animals; Cell Survival; Cells, Cultured; Cytokine Receptor gp130; Flavonoids; Humans; Hypertrophy; Imidazoles; Interleukin-6; Janus Kinases; Leukemia Inhibitory Factor; Mice; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Myocytes, Cardiac; Nitric Oxide; Nitric Oxide Synthase Type II; p38 Mitogen-Activated Protein Kinases; Phosphatidylinositol 3-Kinases; Phosphorylation; Pyridines; Rats; Receptors, Erythropoietin; Recombinant Fusion Proteins; Recombinant Proteins; Reperfusion Injury; Signal Transduction; STAT1 Transcription Factor; STAT3 Transcription Factor | 2013 |
IL-13 mediates the recruitment of reserve cells for fusion during IGF-1-induced hypertrophy of human myotubes.
Topics: Cells, Cultured; Enzyme Inhibitors; Flavonoids; Humans; Hypertrophy; Imidazoles; Insulin-Like Growth Factor I; Interleukin-13; Membrane Fusion; Muscle Fibers, Skeletal; Pyridines | 2007 |
TGFbeta1 regulates endothelial cell spreading and hypertrophy through a Rac-p38-mediated pathway.
Topics: Animals; Cell Line; Cell Shape; Endothelial Cells; Enzyme Inhibitors; Hypertrophy; Imidazoles; MAP Kinase Signaling System; p38 Mitogen-Activated Protein Kinases; Proto-Oncogene Proteins c-akt; Pyridines; Swine; Transforming Growth Factor beta1 | 2008 |
A role for the extracellular signal-regulated kinase and p38 mitogen-activated protein kinases in interleukin-1 beta-stimulated delayed signal tranducer and activator of transcription 3 activation, atrial natriuretic factor expression, and cardiac myocyte
Topics: Acute-Phase Proteins; Animals; Animals, Newborn; Atrial Natriuretic Factor; Cell Nucleus; Cells, Cultured; Culture Media, Serum-Free; Cycloheximide; DNA-Binding Proteins; Enzyme Inhibitors; Flavonoids; Growth Inhibitors; Heart; Heart Ventricles; Hypertrophy; Imidazoles; Interleukin-1; Interleukin-6; JNK Mitogen-Activated Protein Kinases; Kinetics; Leukemia Inhibitory Factor; Lymphokines; MAP Kinase Signaling System; Mitogen-Activated Protein Kinases; Myocardium; p38 Mitogen-Activated Protein Kinases; Phenylephrine; Phosphorylation; Protein Transport; Pyridines; Rats; Rats, Sprague-Dawley; STAT3 Transcription Factor; Trans-Activators | 2001 |